2012
London, UK, 23 April 2012 BTG plc (LSE: BGC), the specialist healthcare company, today announces the successful outcome of VANISH-1, the second and final US pivotal Phase III trial of Varisolve®...
London, UK, 04 April 2012 BTG plc (LSE: BGC), the specialist healthcare company, provides the following update for the year ended 31 March 2012 ahead of the planned publication of its Final...
London, UK, 28 March 2012 Powder for solution for infusion Launched in the UK, BTG, the specialist healthcare company today announces the launch of DigiFab® in the UK through Protherics Medicines...
London, UK, 08 March 2012 Regulatory applications to be submitted in the US and around the world beginning in H2 2012 seeking approval for use in men with CRPC who have not yet received...
London, UK, 20 February 2012 BTG plc (LSE: BGC), the specialist healthcare company today announces that it will be presenting at the Citi Global Health Care Conference in New York, US on Tuesday,...
London, UK, 14 February 2012 BTG plc (LSE: BGC), the specialist healthcare company, announces that Rolf Soderstrom will no longer be leaving the company at the end of March and will continue in...
London, UK, 30 January 2012 Study meets all primary, secondary and tertiary endpoints BTG plc (LSE: BGC), the specialist healthcare company, today announces the successful outcome of VANISH-2, the...
London, UK, 25 January 2012 BTG plc (LSE: BGC), the specialist healthcare company, today publishes its interim management statement for the period from 1 October 2011 to 24 January 2012. Trading...
London, UK, 18 January 2012 BTG plc (LSE: BGC), the specialist healthcare company, today announces that it has received regulatory approval from the US Food and Drug Administration (FDA) for its...
London, UK, 11 January 2012 BTG plc (LSE: BGC), the specialist healthcare company today announces that it will be presenting at the 30th Annual J.P. Morgan Conference on Wednesday 11 January at...
London, UK, 11 December 2012 BTG plc (LSE: BTG), the specialist healthcare company, notes the announcement by Janssen that the US Food and Drug Administration (FDA) has approved the use of...